These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 22039016

  • 1. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M, Wakita D, Satoh T, Kitamura H, Nishimura T.
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [Abstract] [Full Text] [Related]

  • 2. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hünig T, Mittrücker HW, Brüstle A, Kamradt T, Lohoff M.
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [Abstract] [Full Text] [Related]

  • 3. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z, Rezaeifard S, Safaei A, Ghaderi A, Erfani N.
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [Abstract] [Full Text] [Related]

  • 4. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.
    Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY, Wang J, Yin XY, Li L, Zheng L.
    J Immunol; 2010 Aug 01; 185(3):1544-9. PubMed ID: 20581151
    [Abstract] [Full Text] [Related]

  • 5. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS, Kwon BS.
    Cell Immunol; 1999 Feb 25; 192(1):63-71. PubMed ID: 10066348
    [Abstract] [Full Text] [Related]

  • 6. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z, Tang C, Xu S, Zhang B, Zhang X, Moyana T, Yang J, Xiang J.
    Cell Mol Immunol; 2007 Aug 25; 4(4):277-85. PubMed ID: 17764618
    [Abstract] [Full Text] [Related]

  • 7. CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.
    Ma J, Shi LL, Deng YK, Wang H, Cao PP, Long XB, Zhang XH, Liu Y, Zeng M, Liu Z.
    Clin Exp Allergy; 2016 Sep 25; 46(9):1162-75. PubMed ID: 27176491
    [Abstract] [Full Text] [Related]

  • 8. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines.
    Cerwenka A, Carter LL, Reome JB, Swain SL, Dutton RW.
    J Immunol; 1998 Jul 01; 161(1):97-105. PubMed ID: 9647212
    [Abstract] [Full Text] [Related]

  • 9. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I, Kohno K, Tanimoto T, Ikegami H, Kurimoto M.
    J Immunol; 1999 Mar 15; 162(6):3202-11. PubMed ID: 10092771
    [Abstract] [Full Text] [Related]

  • 10. Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.
    Kondo T, Takata H, Matsuki F, Takiguchi M.
    J Immunol; 2009 Feb 15; 182(4):1794-8. PubMed ID: 19201830
    [Abstract] [Full Text] [Related]

  • 11. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A, Mercier BC, Mbitikon-Kobo FM, Arpin C, Teoh DY, McMichael A, Marvel J, Bonnefoy-Bérard N.
    Eur J Immunol; 2009 Oct 15; 39(10):2673-81. PubMed ID: 19634192
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
    Dobrzanski MJ, Reome JB, Dutton RW.
    J Immunol; 1999 Jun 01; 162(11):6671-80. PubMed ID: 10352285
    [Abstract] [Full Text] [Related]

  • 13. The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter.
    Satoh T, Tajima M, Wakita D, Kitamura H, Nishimura T.
    Eur J Immunol; 2012 Sep 01; 42(9):2329-42. PubMed ID: 22674086
    [Abstract] [Full Text] [Related]

  • 14. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
    Rodolfo M, Zilocchi C, Accornero P, Cappetti B, Arioli I, Colombo MP.
    J Immunol; 1999 Aug 15; 163(4):1923-8. PubMed ID: 10438927
    [Abstract] [Full Text] [Related]

  • 15. SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8⁺ T cells in mice.
    Won TJ, Lee YJ, Hyung KE, Yang E, Sohn UD, Min HY, Lee DI, Park SY, Hwang KW.
    Cell Signal; 2015 Jun 15; 27(6):1246-52. PubMed ID: 25762490
    [Abstract] [Full Text] [Related]

  • 16. A T(h)17-polarized cell population that has infiltrated the lung requires cells that convert to IFN-{gamma} production in order to induce airway hyperresponsiveness.
    Ashino S, Wakita D, Shiohama Y, Iwakura Y, Chamoto K, Ohkuri T, Kitamura H, Nishimura T.
    Int Immunol; 2010 Jun 15; 22(6):503-13. PubMed ID: 20501609
    [Abstract] [Full Text] [Related]

  • 17. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.
    Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW.
    J Immunol; 2009 Mar 15; 182(6):3469-81. PubMed ID: 19265125
    [Abstract] [Full Text] [Related]

  • 18. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
    Kosaka A, Wakita D, Matsubara N, Togashi Y, Nishimura S, Kitamura H, Nishimura T.
    Int Immunol; 2007 Mar 15; 19(3):249-56. PubMed ID: 17229818
    [Abstract] [Full Text] [Related]

  • 19. TGF-β and IL-21 cooperatively stimulate activated CD8(+) T cells to differentiate into Tc17 cells.
    Chen HW, Tsai JP, Yao TY, Hsieh CL, Chen IH, Liu SJ.
    Immunol Lett; 2016 Jun 15; 174():23-7. PubMed ID: 27085379
    [Abstract] [Full Text] [Related]

  • 20. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May 15; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.